nodes	percent_of_prediction	percent_of_DWPC	metapath
Rotigotine—CYP1A2—Sorafenib—liver cancer	0.0812	0.316	CbGbCtD
Rotigotine—CYP2D6—Sorafenib—liver cancer	0.0669	0.26	CbGbCtD
Rotigotine—CYP3A4—Sorafenib—liver cancer	0.0426	0.165	CbGbCtD
Rotigotine—CYP2D6—Doxorubicin—liver cancer	0.0406	0.158	CbGbCtD
Rotigotine—CYP3A4—Doxorubicin—liver cancer	0.0258	0.1	CbGbCtD
Rotigotine—Haemoglobin decreased—Sorafenib—liver cancer	0.0138	0.031	CcSEcCtD
Rotigotine—Skin exfoliation—Sorafenib—liver cancer	0.00909	0.0204	CcSEcCtD
Rotigotine—Dysaesthesia—Epirubicin—liver cancer	0.00814	0.0182	CcSEcCtD
Rotigotine—Eczema—Sorafenib—liver cancer	0.00769	0.0172	CcSEcCtD
Rotigotine—Dysaesthesia—Doxorubicin—liver cancer	0.00753	0.0169	CcSEcCtD
Rotigotine—Breast disorder—Sorafenib—liver cancer	0.00625	0.014	CcSEcCtD
Rotigotine—Nasopharyngitis—Sorafenib—liver cancer	0.00618	0.0139	CcSEcCtD
Rotigotine—Erectile dysfunction—Sorafenib—liver cancer	0.0055	0.0123	CcSEcCtD
Rotigotine—Weight decreased—Sorafenib—liver cancer	0.00541	0.0121	CcSEcCtD
Rotigotine—Infestation NOS—Sorafenib—liver cancer	0.00533	0.0119	CcSEcCtD
Rotigotine—Infestation—Sorafenib—liver cancer	0.00533	0.0119	CcSEcCtD
Rotigotine—Connective tissue disorder—Sorafenib—liver cancer	0.0047	0.0105	CcSEcCtD
Rotigotine—Tinnitus—Sorafenib—liver cancer	0.00446	0.00999	CcSEcCtD
Rotigotine—Angiopathy—Sorafenib—liver cancer	0.00434	0.00973	CcSEcCtD
Rotigotine—Immune system disorder—Sorafenib—liver cancer	0.00432	0.00968	CcSEcCtD
Rotigotine—Mediastinal disorder—Sorafenib—liver cancer	0.00431	0.00966	CcSEcCtD
Rotigotine—Mental disorder—Sorafenib—liver cancer	0.00419	0.00939	CcSEcCtD
Rotigotine—Erythema—Sorafenib—liver cancer	0.00416	0.00933	CcSEcCtD
Rotigotine—Malnutrition—Sorafenib—liver cancer	0.00416	0.00933	CcSEcCtD
Rotigotine—Muscle spasms—Sorafenib—liver cancer	0.004	0.00897	CcSEcCtD
Rotigotine—Angioedema—Sorafenib—liver cancer	0.0038	0.00853	CcSEcCtD
Rotigotine—Dyskinesia—Epirubicin—liver cancer	0.00375	0.00839	CcSEcCtD
Rotigotine—Syncope—Sorafenib—liver cancer	0.00373	0.00837	CcSEcCtD
Rotigotine—Loss of consciousness—Sorafenib—liver cancer	0.00366	0.0082	CcSEcCtD
Rotigotine—Cough—Sorafenib—liver cancer	0.00363	0.00814	CcSEcCtD
Rotigotine—Inflammation—Epirubicin—liver cancer	0.00363	0.00813	CcSEcCtD
Rotigotine—Hypertension—Sorafenib—liver cancer	0.00359	0.00806	CcSEcCtD
Rotigotine—Musculoskeletal pain—Epirubicin—liver cancer	0.00356	0.00798	CcSEcCtD
Rotigotine—Arthralgia—Sorafenib—liver cancer	0.00354	0.00794	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00352	0.00789	CcSEcCtD
Rotigotine—Hiccups—Epirubicin—liver cancer	0.00352	0.00789	CcSEcCtD
Rotigotine—Abnormal dreams—Epirubicin—liver cancer	0.00348	0.0078	CcSEcCtD
Rotigotine—Dry mouth—Sorafenib—liver cancer	0.00347	0.00777	CcSEcCtD
Rotigotine—Dyskinesia—Doxorubicin—liver cancer	0.00347	0.00777	CcSEcCtD
Rotigotine—Infection—Sorafenib—liver cancer	0.00338	0.00757	CcSEcCtD
Rotigotine—Skin exfoliation—Epirubicin—liver cancer	0.00336	0.00753	CcSEcCtD
Rotigotine—Inflammation—Doxorubicin—liver cancer	0.00336	0.00752	CcSEcCtD
Rotigotine—Shock—Sorafenib—liver cancer	0.00334	0.00749	CcSEcCtD
Rotigotine—Fluid retention—Epirubicin—liver cancer	0.00334	0.00749	CcSEcCtD
Rotigotine—Nervous system disorder—Sorafenib—liver cancer	0.00333	0.00747	CcSEcCtD
Rotigotine—Skin disorder—Sorafenib—liver cancer	0.0033	0.0074	CcSEcCtD
Rotigotine—Musculoskeletal pain—Doxorubicin—liver cancer	0.0033	0.00739	CcSEcCtD
Rotigotine—Hiccups—Doxorubicin—liver cancer	0.00326	0.0073	CcSEcCtD
Rotigotine—Anorexia—Sorafenib—liver cancer	0.00324	0.00726	CcSEcCtD
Rotigotine—Abnormal dreams—Doxorubicin—liver cancer	0.00322	0.00721	CcSEcCtD
Rotigotine—Skin exfoliation—Doxorubicin—liver cancer	0.00311	0.00697	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.0031	0.00694	CcSEcCtD
Rotigotine—Fluid retention—Doxorubicin—liver cancer	0.00309	0.00693	CcSEcCtD
Rotigotine—Abnormal vision—Epirubicin—liver cancer	0.00307	0.00688	CcSEcCtD
Rotigotine—Dyspepsia—Sorafenib—liver cancer	0.00299	0.0067	CcSEcCtD
Rotigotine—Decreased appetite—Sorafenib—liver cancer	0.00295	0.00662	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Sorafenib—liver cancer	0.00293	0.00657	CcSEcCtD
Rotigotine—Fatigue—Sorafenib—liver cancer	0.00293	0.00657	CcSEcCtD
Rotigotine—Pain—Sorafenib—liver cancer	0.00291	0.00651	CcSEcCtD
Rotigotine—Constipation—Sorafenib—liver cancer	0.00291	0.00651	CcSEcCtD
Rotigotine—Eczema—Epirubicin—liver cancer	0.00284	0.00637	CcSEcCtD
Rotigotine—Abnormal vision—Doxorubicin—liver cancer	0.00284	0.00637	CcSEcCtD
Rotigotine—Hot flush—Epirubicin—liver cancer	0.00273	0.00612	CcSEcCtD
Rotigotine—Menopausal symptoms—Epirubicin—liver cancer	0.00271	0.00607	CcSEcCtD
Rotigotine—Urticaria—Sorafenib—liver cancer	0.0027	0.00605	CcSEcCtD
Rotigotine—Eczema—Doxorubicin—liver cancer	0.00263	0.0059	CcSEcCtD
Rotigotine—Lethargy—Epirubicin—liver cancer	0.00261	0.00584	CcSEcCtD
Rotigotine—Hot flush—Doxorubicin—liver cancer	0.00253	0.00566	CcSEcCtD
Rotigotine—Menopausal symptoms—Doxorubicin—liver cancer	0.00251	0.00562	CcSEcCtD
Rotigotine—Hypersensitivity—Sorafenib—liver cancer	0.0025	0.00561	CcSEcCtD
Rotigotine—Asthenia—Sorafenib—liver cancer	0.00244	0.00546	CcSEcCtD
Rotigotine—Lethargy—Doxorubicin—liver cancer	0.00241	0.00541	CcSEcCtD
Rotigotine—Pruritus—Sorafenib—liver cancer	0.0024	0.00539	CcSEcCtD
Rotigotine—Orthostatic hypotension—Epirubicin—liver cancer	0.00233	0.00523	CcSEcCtD
Rotigotine—Diarrhoea—Sorafenib—liver cancer	0.00233	0.00521	CcSEcCtD
Rotigotine—Breast disorder—Epirubicin—liver cancer	0.00231	0.00517	CcSEcCtD
Rotigotine—Nasopharyngitis—Epirubicin—liver cancer	0.00229	0.00512	CcSEcCtD
Rotigotine—Dizziness—Sorafenib—liver cancer	0.00225	0.00504	CcSEcCtD
Rotigotine—Vomiting—Sorafenib—liver cancer	0.00216	0.00484	CcSEcCtD
Rotigotine—Orthostatic hypotension—Doxorubicin—liver cancer	0.00216	0.00484	CcSEcCtD
Rotigotine—Rash—Sorafenib—liver cancer	0.00214	0.0048	CcSEcCtD
Rotigotine—Dermatitis—Sorafenib—liver cancer	0.00214	0.0048	CcSEcCtD
Rotigotine—Breast disorder—Doxorubicin—liver cancer	0.00214	0.00479	CcSEcCtD
Rotigotine—Headache—Sorafenib—liver cancer	0.00213	0.00477	CcSEcCtD
Rotigotine—Nasopharyngitis—Doxorubicin—liver cancer	0.00211	0.00474	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Epirubicin—liver cancer	0.00205	0.0046	CcSEcCtD
Rotigotine—Nausea—Sorafenib—liver cancer	0.00202	0.00452	CcSEcCtD
Rotigotine—Weight increased—Epirubicin—liver cancer	0.00201	0.0045	CcSEcCtD
Rotigotine—Weight decreased—Epirubicin—liver cancer	0.002	0.00448	CcSEcCtD
Rotigotine—Infestation NOS—Epirubicin—liver cancer	0.00197	0.00441	CcSEcCtD
Rotigotine—Infestation—Epirubicin—liver cancer	0.00197	0.00441	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Doxorubicin—liver cancer	0.0019	0.00426	CcSEcCtD
Rotigotine—Weight increased—Doxorubicin—liver cancer	0.00186	0.00417	CcSEcCtD
Rotigotine—Weight decreased—Doxorubicin—liver cancer	0.00185	0.00414	CcSEcCtD
Rotigotine—Sinusitis—Epirubicin—liver cancer	0.00185	0.00414	CcSEcCtD
Rotigotine—Infestation—Doxorubicin—liver cancer	0.00182	0.00408	CcSEcCtD
Rotigotine—Infestation NOS—Doxorubicin—liver cancer	0.00182	0.00408	CcSEcCtD
Rotigotine—Oedema peripheral—Epirubicin—liver cancer	0.00174	0.0039	CcSEcCtD
Rotigotine—Connective tissue disorder—Epirubicin—liver cancer	0.00174	0.00389	CcSEcCtD
Rotigotine—Sinusitis—Doxorubicin—liver cancer	0.00171	0.00383	CcSEcCtD
Rotigotine—Visual impairment—Epirubicin—liver cancer	0.0017	0.00382	CcSEcCtD
Rotigotine—Tinnitus—Epirubicin—liver cancer	0.00165	0.00369	CcSEcCtD
Rotigotine—Oedema peripheral—Doxorubicin—liver cancer	0.00161	0.00361	CcSEcCtD
Rotigotine—Connective tissue disorder—Doxorubicin—liver cancer	0.00161	0.0036	CcSEcCtD
Rotigotine—Angiopathy—Epirubicin—liver cancer	0.0016	0.00359	CcSEcCtD
Rotigotine—Immune system disorder—Epirubicin—liver cancer	0.0016	0.00358	CcSEcCtD
Rotigotine—Mediastinal disorder—Epirubicin—liver cancer	0.00159	0.00357	CcSEcCtD
Rotigotine—Visual impairment—Doxorubicin—liver cancer	0.00158	0.00353	CcSEcCtD
Rotigotine—Mental disorder—Epirubicin—liver cancer	0.00155	0.00347	CcSEcCtD
Rotigotine—Erythema—Epirubicin—liver cancer	0.00154	0.00345	CcSEcCtD
Rotigotine—Malnutrition—Epirubicin—liver cancer	0.00154	0.00345	CcSEcCtD
Rotigotine—Tinnitus—Doxorubicin—liver cancer	0.00153	0.00342	CcSEcCtD
Rotigotine—Angiopathy—Doxorubicin—liver cancer	0.00148	0.00333	CcSEcCtD
Rotigotine—Muscle spasms—Epirubicin—liver cancer	0.00148	0.00332	CcSEcCtD
Rotigotine—Immune system disorder—Doxorubicin—liver cancer	0.00148	0.00331	CcSEcCtD
Rotigotine—Mediastinal disorder—Doxorubicin—liver cancer	0.00147	0.0033	CcSEcCtD
Rotigotine—Mental disorder—Doxorubicin—liver cancer	0.00143	0.00321	CcSEcCtD
Rotigotine—Ill-defined disorder—Epirubicin—liver cancer	0.00143	0.0032	CcSEcCtD
Rotigotine—Erythema—Doxorubicin—liver cancer	0.00142	0.00319	CcSEcCtD
Rotigotine—Malnutrition—Doxorubicin—liver cancer	0.00142	0.00319	CcSEcCtD
Rotigotine—Agitation—Epirubicin—liver cancer	0.00141	0.00317	CcSEcCtD
Rotigotine—Malaise—Epirubicin—liver cancer	0.00139	0.00311	CcSEcCtD
Rotigotine—Vertigo—Epirubicin—liver cancer	0.00138	0.0031	CcSEcCtD
Rotigotine—Syncope—Epirubicin—liver cancer	0.00138	0.00309	CcSEcCtD
Rotigotine—Muscle spasms—Doxorubicin—liver cancer	0.00137	0.00307	CcSEcCtD
Rotigotine—Loss of consciousness—Epirubicin—liver cancer	0.00135	0.00303	CcSEcCtD
Rotigotine—Cough—Epirubicin—liver cancer	0.00134	0.00301	CcSEcCtD
Rotigotine—Hypertension—Epirubicin—liver cancer	0.00133	0.00298	CcSEcCtD
Rotigotine—Ill-defined disorder—Doxorubicin—liver cancer	0.00132	0.00296	CcSEcCtD
Rotigotine—Arthralgia—Epirubicin—liver cancer	0.00131	0.00294	CcSEcCtD
Rotigotine—Agitation—Doxorubicin—liver cancer	0.00131	0.00293	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.0013	0.00292	CcSEcCtD
Rotigotine—Discomfort—Epirubicin—liver cancer	0.00129	0.0029	CcSEcCtD
Rotigotine—Malaise—Doxorubicin—liver cancer	0.00128	0.00288	CcSEcCtD
Rotigotine—Dry mouth—Epirubicin—liver cancer	0.00128	0.00287	CcSEcCtD
Rotigotine—Vertigo—Doxorubicin—liver cancer	0.00128	0.00287	CcSEcCtD
Rotigotine—Syncope—Doxorubicin—liver cancer	0.00128	0.00286	CcSEcCtD
Rotigotine—Confusional state—Epirubicin—liver cancer	0.00127	0.00284	CcSEcCtD
Rotigotine—Loss of consciousness—Doxorubicin—liver cancer	0.00125	0.0028	CcSEcCtD
Rotigotine—Infection—Epirubicin—liver cancer	0.00125	0.0028	CcSEcCtD
Rotigotine—Cough—Doxorubicin—liver cancer	0.00124	0.00278	CcSEcCtD
Rotigotine—Shock—Epirubicin—liver cancer	0.00124	0.00277	CcSEcCtD
Rotigotine—Nervous system disorder—Epirubicin—liver cancer	0.00123	0.00276	CcSEcCtD
Rotigotine—Hypertension—Doxorubicin—liver cancer	0.00123	0.00275	CcSEcCtD
Rotigotine—Skin disorder—Epirubicin—liver cancer	0.00122	0.00273	CcSEcCtD
Rotigotine—Hyperhidrosis—Epirubicin—liver cancer	0.00121	0.00272	CcSEcCtD
Rotigotine—Arthralgia—Doxorubicin—liver cancer	0.00121	0.00272	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.0012	0.0027	CcSEcCtD
Rotigotine—Discomfort—Doxorubicin—liver cancer	0.0012	0.00268	CcSEcCtD
Rotigotine—Anorexia—Epirubicin—liver cancer	0.0012	0.00268	CcSEcCtD
Rotigotine—Dry mouth—Doxorubicin—liver cancer	0.00119	0.00266	CcSEcCtD
Rotigotine—Hypotension—Epirubicin—liver cancer	0.00117	0.00263	CcSEcCtD
Rotigotine—Confusional state—Doxorubicin—liver cancer	0.00117	0.00263	CcSEcCtD
Rotigotine—Infection—Doxorubicin—liver cancer	0.00115	0.00259	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00114	0.00256	CcSEcCtD
Rotigotine—Shock—Doxorubicin—liver cancer	0.00114	0.00256	CcSEcCtD
Rotigotine—Nervous system disorder—Doxorubicin—liver cancer	0.00114	0.00255	CcSEcCtD
Rotigotine—Insomnia—Epirubicin—liver cancer	0.00114	0.00255	CcSEcCtD
Rotigotine—Skin disorder—Doxorubicin—liver cancer	0.00113	0.00253	CcSEcCtD
Rotigotine—Paraesthesia—Epirubicin—liver cancer	0.00113	0.00253	CcSEcCtD
Rotigotine—Hyperhidrosis—Doxorubicin—liver cancer	0.00112	0.00252	CcSEcCtD
Rotigotine—Somnolence—Epirubicin—liver cancer	0.00112	0.0025	CcSEcCtD
Rotigotine—Anorexia—Doxorubicin—liver cancer	0.00111	0.00248	CcSEcCtD
Rotigotine—Dyspepsia—Epirubicin—liver cancer	0.00111	0.00248	CcSEcCtD
Rotigotine—Decreased appetite—Epirubicin—liver cancer	0.00109	0.00245	CcSEcCtD
Rotigotine—Hypotension—Doxorubicin—liver cancer	0.00109	0.00243	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Epirubicin—liver cancer	0.00108	0.00243	CcSEcCtD
Rotigotine—Fatigue—Epirubicin—liver cancer	0.00108	0.00243	CcSEcCtD
Rotigotine—Constipation—Epirubicin—liver cancer	0.00107	0.00241	CcSEcCtD
Rotigotine—Pain—Epirubicin—liver cancer	0.00107	0.00241	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00106	0.00237	CcSEcCtD
Rotigotine—Insomnia—Doxorubicin—liver cancer	0.00105	0.00236	CcSEcCtD
Rotigotine—Paraesthesia—Doxorubicin—liver cancer	0.00104	0.00234	CcSEcCtD
Rotigotine—Feeling abnormal—Epirubicin—liver cancer	0.00103	0.00232	CcSEcCtD
Rotigotine—Somnolence—Doxorubicin—liver cancer	0.00103	0.00232	CcSEcCtD
Rotigotine—Dyspepsia—Doxorubicin—liver cancer	0.00102	0.00229	CcSEcCtD
Rotigotine—Decreased appetite—Doxorubicin—liver cancer	0.00101	0.00226	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.001	0.00225	CcSEcCtD
Rotigotine—Fatigue—Doxorubicin—liver cancer	0.001	0.00225	CcSEcCtD
Rotigotine—Urticaria—Epirubicin—liver cancer	0.000998	0.00224	CcSEcCtD
Rotigotine—Pain—Doxorubicin—liver cancer	0.000994	0.00223	CcSEcCtD
Rotigotine—Constipation—Doxorubicin—liver cancer	0.000994	0.00223	CcSEcCtD
Rotigotine—Feeling abnormal—Doxorubicin—liver cancer	0.000958	0.00215	CcSEcCtD
Rotigotine—Hypersensitivity—Epirubicin—liver cancer	0.000925	0.00207	CcSEcCtD
Rotigotine—Urticaria—Doxorubicin—liver cancer	0.000923	0.00207	CcSEcCtD
Rotigotine—Asthenia—Epirubicin—liver cancer	0.000901	0.00202	CcSEcCtD
Rotigotine—Pruritus—Epirubicin—liver cancer	0.000889	0.00199	CcSEcCtD
Rotigotine—Diarrhoea—Epirubicin—liver cancer	0.000859	0.00193	CcSEcCtD
Rotigotine—Hypersensitivity—Doxorubicin—liver cancer	0.000856	0.00192	CcSEcCtD
Rotigotine—Asthenia—Doxorubicin—liver cancer	0.000834	0.00187	CcSEcCtD
Rotigotine—Dizziness—Epirubicin—liver cancer	0.000831	0.00186	CcSEcCtD
Rotigotine—Pruritus—Doxorubicin—liver cancer	0.000822	0.00184	CcSEcCtD
Rotigotine—Vomiting—Epirubicin—liver cancer	0.000799	0.00179	CcSEcCtD
Rotigotine—Diarrhoea—Doxorubicin—liver cancer	0.000795	0.00178	CcSEcCtD
Rotigotine—Rash—Epirubicin—liver cancer	0.000792	0.00177	CcSEcCtD
Rotigotine—Dermatitis—Epirubicin—liver cancer	0.000791	0.00177	CcSEcCtD
Rotigotine—Headache—Epirubicin—liver cancer	0.000787	0.00176	CcSEcCtD
Rotigotine—Dizziness—Doxorubicin—liver cancer	0.000768	0.00172	CcSEcCtD
Rotigotine—Nausea—Epirubicin—liver cancer	0.000746	0.00167	CcSEcCtD
Rotigotine—Vomiting—Doxorubicin—liver cancer	0.000739	0.00166	CcSEcCtD
Rotigotine—Rash—Doxorubicin—liver cancer	0.000733	0.00164	CcSEcCtD
Rotigotine—Dermatitis—Doxorubicin—liver cancer	0.000732	0.00164	CcSEcCtD
Rotigotine—Headache—Doxorubicin—liver cancer	0.000728	0.00163	CcSEcCtD
Rotigotine—Nausea—Doxorubicin—liver cancer	0.00069	0.00155	CcSEcCtD
Rotigotine—HTR1A—Signaling Pathways—APC—liver cancer	5.44e-05	0.000184	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GGT1—liver cancer	5.44e-05	0.000183	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GOT1—liver cancer	5.44e-05	0.000183	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—PIK3CA—liver cancer	5.44e-05	0.000183	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CRABP1—liver cancer	5.44e-05	0.000183	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—SERPINE1—liver cancer	5.43e-05	0.000183	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MTOR—liver cancer	5.39e-05	0.000182	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—PIK3CB—liver cancer	5.39e-05	0.000182	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—KRAS—liver cancer	5.38e-05	0.000181	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GOT2—liver cancer	5.34e-05	0.00018	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—BRAF—liver cancer	5.3e-05	0.000179	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—MYC—liver cancer	5.24e-05	0.000177	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TGFB1—liver cancer	5.23e-05	0.000176	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—KDR—liver cancer	5.19e-05	0.000175	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MAPK14—liver cancer	5.15e-05	0.000174	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—HRAS—liver cancer	5.14e-05	0.000173	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—BRAF—liver cancer	5.12e-05	0.000173	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CDKN1B—liver cancer	5.06e-05	0.00017	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—ESR1—liver cancer	5.06e-05	0.00017	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CYP2E1—liver cancer	5.02e-05	0.000169	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—PIK3CA—liver cancer	5.01e-05	0.000169	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—AKT1—liver cancer	5e-05	0.000169	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—F2—liver cancer	4.99e-05	0.000168	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—RAF1—liver cancer	4.97e-05	0.000168	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PIK3CD—liver cancer	4.96e-05	0.000167	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CASP3—liver cancer	4.96e-05	0.000167	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—IL2—liver cancer	4.95e-05	0.000167	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—PIK3CA—liver cancer	4.94e-05	0.000167	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—IL6—liver cancer	4.92e-05	0.000166	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—PIK3CA—liver cancer	4.91e-05	0.000166	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—SERPINE1—liver cancer	4.9e-05	0.000165	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—RAF1—liver cancer	4.9e-05	0.000165	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GSTP1—liver cancer	4.89e-05	0.000165	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.86e-05	0.000164	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—KRAS—liver cancer	4.85e-05	0.000164	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PIK3CB—liver cancer	4.85e-05	0.000164	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MTOR—liver cancer	4.85e-05	0.000164	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—KRAS—liver cancer	4.84e-05	0.000163	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CCND1—liver cancer	4.82e-05	0.000163	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—HMOX1—liver cancer	4.82e-05	0.000162	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—JUN—liver cancer	4.81e-05	0.000162	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PIK3CB—liver cancer	4.79e-05	0.000161	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MTOR—liver cancer	4.79e-05	0.000161	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PIK3CD—liver cancer	4.79e-05	0.000161	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—APC—liver cancer	4.78e-05	0.000161	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3CG—liver cancer	4.78e-05	0.000161	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CTNNB1—liver cancer	4.78e-05	0.000161	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—HPGDS—liver cancer	4.75e-05	0.00016	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—PIK3CA—liver cancer	4.74e-05	0.00016	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—SERPINE1—liver cancer	4.73e-05	0.00016	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CYCS—liver cancer	4.7e-05	0.000158	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—KRAS—liver cancer	4.68e-05	0.000158	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MMP9—liver cancer	4.68e-05	0.000158	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CDKN1A—liver cancer	4.67e-05	0.000157	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—HRAS—liver cancer	4.63e-05	0.000156	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GGT1—liver cancer	4.61e-05	0.000155	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GOT1—liver cancer	4.61e-05	0.000155	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—HRAS—liver cancer	4.57e-05	0.000154	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MAPK8—liver cancer	4.55e-05	0.000154	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CDKN1B—liver cancer	4.55e-05	0.000153	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—AKT1—liver cancer	4.54e-05	0.000153	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—AKT1—liver cancer	4.5e-05	0.000152	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—BRAF—liver cancer	4.49e-05	0.000151	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CDKN1B—liver cancer	4.49e-05	0.000151	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GSTM1—liver cancer	4.49e-05	0.000151	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CASP3—liver cancer	4.46e-05	0.00015	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—PIK3CA—liver cancer	4.46e-05	0.00015	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—IL2—liver cancer	4.45e-05	0.00015	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—PIK3CA—liver cancer	4.45e-05	0.00015	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—AKT1—liver cancer	4.44e-05	0.00015	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—IL6—liver cancer	4.43e-05	0.000149	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—RAF1—liver cancer	4.43e-05	0.000149	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CASP3—liver cancer	4.4e-05	0.000148	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—IL2—liver cancer	4.4e-05	0.000148	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—IL6—liver cancer	4.37e-05	0.000147	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CCND1—liver cancer	4.34e-05	0.000146	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—JUN—liver cancer	4.33e-05	0.000146	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MTOR—liver cancer	4.32e-05	0.000146	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PIK3CB—liver cancer	4.32e-05	0.000146	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TP53—liver cancer	4.31e-05	0.000145	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—PIK3CA—liver cancer	4.3e-05	0.000145	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CTNNB1—liver cancer	4.3e-05	0.000145	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CCND1—liver cancer	4.28e-05	0.000144	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—JUN—liver cancer	4.28e-05	0.000144	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—RAF1—liver cancer	4.27e-05	0.000144	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CYP1A1—liver cancer	4.26e-05	0.000144	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CTNNB1—liver cancer	4.24e-05	0.000143	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PSMD10—liver cancer	4.24e-05	0.000143	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PSMA4—liver cancer	4.24e-05	0.000143	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MMP9—liver cancer	4.22e-05	0.000142	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—VEGFA—liver cancer	4.21e-05	0.000142	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3CD—liver cancer	4.2e-05	0.000142	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CDKN1A—liver cancer	4.2e-05	0.000142	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MTOR—liver cancer	4.17e-05	0.000141	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PIK3CB—liver cancer	4.17e-05	0.000141	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—STAT3—liver cancer	4.16e-05	0.00014	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—PIK3CA—liver cancer	4.16e-05	0.00014	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MMP9—liver cancer	4.16e-05	0.00014	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—SERPINE1—liver cancer	4.16e-05	0.00014	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CDKN1A—liver cancer	4.14e-05	0.00014	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GSTP1—liver cancer	4.14e-05	0.00014	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—HRAS—liver cancer	4.13e-05	0.000139	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GOT2—liver cancer	4.12e-05	0.000139	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—HRAS—liver cancer	4.12e-05	0.000139	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—KRAS—liver cancer	4.11e-05	0.000139	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MAPK8—liver cancer	4.1e-05	0.000138	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—AKT1—liver cancer	4.09e-05	0.000138	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—HMOX1—liver cancer	4.08e-05	0.000138	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CDKN1B—liver cancer	4.05e-05	0.000137	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MAPK8—liver cancer	4.05e-05	0.000136	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—AKT1—liver cancer	4.03e-05	0.000136	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—AKT1—liver cancer	4.01e-05	0.000135	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—HRAS—liver cancer	3.98e-05	0.000134	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CASP3—liver cancer	3.97e-05	0.000134	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—MTHFR—liver cancer	3.97e-05	0.000134	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—IL2—liver cancer	3.97e-05	0.000134	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—IL6—liver cancer	3.95e-05	0.000133	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—IL6—liver cancer	3.94e-05	0.000133	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CDKN1B—liver cancer	3.91e-05	0.000132	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PPARA—liver cancer	3.89e-05	0.000131	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP2E1—liver cancer	3.87e-05	0.000131	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—AKT1—liver cancer	3.87e-05	0.000131	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MYC—liver cancer	3.87e-05	0.00013	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CCND1—liver cancer	3.87e-05	0.00013	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—JUN—liver cancer	3.86e-05	0.00013	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TGFB1—liver cancer	3.86e-05	0.00013	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CASP3—liver cancer	3.84e-05	0.000129	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CTNNB1—liver cancer	3.83e-05	0.000129	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—IL2—liver cancer	3.83e-05	0.000129	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—IL6—liver cancer	3.81e-05	0.000129	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GSTM1—liver cancer	3.8e-05	0.000128	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—VEGFA—liver cancer	3.79e-05	0.000128	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—PIK3CA—liver cancer	3.78e-05	0.000127	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MMP9—liver cancer	3.76e-05	0.000127	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—RAF1—liver cancer	3.75e-05	0.000126	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—STAT3—liver cancer	3.75e-05	0.000126	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CDKN1A—liver cancer	3.74e-05	0.000126	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—VEGFA—liver cancer	3.74e-05	0.000126	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CCND1—liver cancer	3.73e-05	0.000126	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—JUN—liver cancer	3.73e-05	0.000126	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—STAT3—liver cancer	3.7e-05	0.000125	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CTNNB1—liver cancer	3.7e-05	0.000125	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MTOR—liver cancer	3.66e-05	0.000123	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3CB—liver cancer	3.66e-05	0.000123	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MAPK8—liver cancer	3.65e-05	0.000123	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—AKT1—liver cancer	3.64e-05	0.000123	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—AKT1—liver cancer	3.64e-05	0.000123	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MMP9—liver cancer	3.63e-05	0.000122	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYCS—liver cancer	3.62e-05	0.000122	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CDKN1A—liver cancer	3.61e-05	0.000122	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CYP1A1—liver cancer	3.61e-05	0.000122	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—KRAS—liver cancer	3.57e-05	0.000121	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GGT1—liver cancer	3.56e-05	0.00012	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GOT1—liver cancer	3.56e-05	0.00012	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MAPK8—liver cancer	3.53e-05	0.000119	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—AKT1—liver cancer	3.52e-05	0.000119	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—HRAS—liver cancer	3.5e-05	0.000118	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MYC—liver cancer	3.48e-05	0.000117	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TGFB1—liver cancer	3.47e-05	0.000117	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MYC—liver cancer	3.44e-05	0.000116	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CDKN1B—liver cancer	3.44e-05	0.000116	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TGFB1—liver cancer	3.43e-05	0.000116	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—AKT1—liver cancer	3.4e-05	0.000115	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—VEGFA—liver cancer	3.37e-05	0.000114	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CASP3—liver cancer	3.37e-05	0.000114	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IL2—liver cancer	3.36e-05	0.000113	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—MTHFR—liver cancer	3.36e-05	0.000113	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—IL6—liver cancer	3.35e-05	0.000113	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—STAT3—liver cancer	3.34e-05	0.000113	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CG—liver cancer	3.33e-05	0.000112	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PPARA—liver cancer	3.3e-05	0.000111	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—PIK3CA—liver cancer	3.28e-05	0.000111	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CCND1—liver cancer	3.28e-05	0.000111	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—JUN—liver cancer	3.27e-05	0.00011	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—VEGFA—liver cancer	3.26e-05	0.00011	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CTNNB1—liver cancer	3.25e-05	0.000109	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—STAT3—liver cancer	3.22e-05	0.000109	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—KRAS—liver cancer	3.22e-05	0.000109	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PPARG—liver cancer	3.22e-05	0.000108	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GSTP1—liver cancer	3.19e-05	0.000108	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MMP9—liver cancer	3.18e-05	0.000107	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TP53—liver cancer	3.18e-05	0.000107	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—KRAS—liver cancer	3.18e-05	0.000107	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CDKN1A—liver cancer	3.17e-05	0.000107	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—HMOX1—liver cancer	3.15e-05	0.000106	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MYC—liver cancer	3.1e-05	0.000105	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MAPK8—liver cancer	3.1e-05	0.000104	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TGFB1—liver cancer	3.1e-05	0.000104	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—AKT1—liver cancer	3.09e-05	0.000104	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—HRAS—liver cancer	3.04e-05	0.000102	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MYC—liver cancer	3e-05	0.000101	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TGFB1—liver cancer	2.99e-05	0.000101	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.96e-05	9.99e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PIK3CA—liver cancer	2.96e-05	9.97e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GSTM1—liver cancer	2.94e-05	9.9e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CD—liver cancer	2.93e-05	9.88e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PIK3CA—liver cancer	2.92e-05	9.84e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—IL6—liver cancer	2.91e-05	9.81e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ALB—liver cancer	2.89e-05	9.76e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—KRAS—liver cancer	2.87e-05	9.67e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TP53—liver cancer	2.86e-05	9.64e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—VEGFA—liver cancer	2.86e-05	9.64e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—STAT3—liver cancer	2.83e-05	9.54e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CG—liver cancer	2.82e-05	9.52e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TP53—liver cancer	2.82e-05	9.52e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP1A1—liver cancer	2.78e-05	9.38e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—KRAS—liver cancer	2.77e-05	9.33e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—HRAS—liver cancer	2.74e-05	9.22e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PPARG—liver cancer	2.73e-05	9.19e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—HRAS—liver cancer	2.7e-05	9.1e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—AKT1—liver cancer	2.68e-05	9.05e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PIK3CA—liver cancer	2.63e-05	8.88e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MYC—liver cancer	2.63e-05	8.87e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TGFB1—liver cancer	2.62e-05	8.85e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—IL6—liver cancer	2.62e-05	8.83e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—MTHFR—liver cancer	2.59e-05	8.75e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—IL6—liver cancer	2.58e-05	8.71e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CB—liver cancer	2.55e-05	8.61e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TP53—liver cancer	2.55e-05	8.59e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PPARA—liver cancer	2.55e-05	8.58e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PIK3CA—liver cancer	2.54e-05	8.57e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CD—liver cancer	2.48e-05	8.37e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TP53—liver cancer	2.46e-05	8.29e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ALB—liver cancer	2.45e-05	8.26e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—HRAS—liver cancer	2.44e-05	8.22e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—KRAS—liver cancer	2.43e-05	8.19e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—AKT1—liver cancer	2.42e-05	8.14e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—AKT1—liver cancer	2.38e-05	8.04e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—HRAS—liver cancer	2.35e-05	7.93e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—IL6—liver cancer	2.33e-05	7.86e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—IL6—liver cancer	2.25e-05	7.59e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3CA—liver cancer	2.23e-05	7.53e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CG—liver cancer	2.18e-05	7.35e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CB—liver cancer	2.16e-05	7.3e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TP53—liver cancer	2.16e-05	7.28e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—AKT1—liver cancer	2.15e-05	7.25e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PPARG—liver cancer	2.1e-05	7.09e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—AKT1—liver cancer	2.08e-05	7e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—HRAS—liver cancer	2.07e-05	6.96e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IL6—liver cancer	1.98e-05	6.67e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CD—liver cancer	1.92e-05	6.46e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ALB—liver cancer	1.89e-05	6.38e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—AKT1—liver cancer	1.82e-05	6.15e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CB—liver cancer	1.67e-05	5.63e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CA—liver cancer	1.56e-05	5.25e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CA—liver cancer	1.32e-05	4.45e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—AKT1—liver cancer	1.27e-05	4.29e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—AKT1—liver cancer	1.08e-05	3.63e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CA—liver cancer	1.02e-05	3.43e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—AKT1—liver cancer	8.32e-06	2.8e-05	CbGpPWpGaD
